The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib
Titel:
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib
Auteur:
Mulas, Olga Abruzzese, Elisabetta Luciano, Luigiana Iurlo, Alessandra Attolico, Immacolata Castagnetti, Fausto Galimberti, Sara Bonifacio, Massimiliano Annunziata, Mario Gozzini, Antonella Orlandi, Ester Maria Stagno, Fabio Binotto, Gianni Pregno, Patrizia Fozza, Claudio Loi, Maurizio Trawinska, Malgorzata Monika De Gregorio, Fiorenza Cattaneo, Daniele Albano, Francesco Iezza, Miriam Baratè, Claudia Scaffidi, Luigi Elena, Chiara Giai, Valentina Scalzulli, Emilia Breccia, Massimo La Nasa, Giorgio Caocci, Giovanni